GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2012

No-Strings-Attached CDx Service Launched

  • Singapore-based Dx assays launched a no-strings-attached, fee-for-service companion diagnostic initiative, which it says ensures that its clients retain full control and ownership over the whole development process, from discovery through to marketing and sales of both drug and companion diagnostics. The initiative includes a complete package from initial assay development for biomarker discovery, through to support for assay validation in clinical trials, and manufacturing and regulatory assistance.

    Dx assays offers molecular diagnostic assay development, verification, validation, and services for the development of molecular and companion diagnostics, including laboratory developed tests and genetic biomarker assays. “The simple fee-for-service model offers pharmaceutical partners exclusive rights to the diagnostics, allowing maximum flexibility on decision making and commercialization strategy through development for multiple platforms and markets,” states John Thornback, Ph.D., Dx assays CEO.

    “The feedback we have had is that pharmaceutical companies are currently feeling they are facing a risk in traditional companion diagnostic development deals. Millions of dollars are spent on drug development but, for successful commercialization, they are fully dependent on an external diagnostic partner for launching and marketing the companion diagnostic. The Dx assays model gives the control back to the pharmaceutical companies.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »